Kalle Ojala

The Institute for Molecular Medicine Finland engages in research, development, and training in molecular medicines. The private company is based in Helsinki, Finland.

Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland.

Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland.

Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland.

Miradore Oy operates as a software company which specializes in providing cloud-based solutions for managing information technology devices. It offers Miradore Online, a cloud-based Mobile Device Management (MDM) solution that safeguards company’s data and devices. The firm also provides hardware and software asset management, operating system and software deployment, patch management, endpoint backup, and remote assistance and control. The company was founded by Mika Liukko and Paul Palojärvi in 2006 and is headquartered in Lappeenranta, Finland.

NewIcon Oy develops and manufactures pharmacy automation systems for hospitals and pharmacies. Its products include automated dispensing systems and cabinets, as well as compounding systems for intravenous antibiotics. The company was founded by Ossi Parviainen on January 4, 2007 and is headquartered in Kuopio, Finland.

Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland.

Meles Consulting Oy provides management consulting services. The private company is based in Espoo, Finland. The CEO of the Finnish company is Pekka Ilmari Simula.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014.

HVR Cardio Oy is a Finnish cardiovascular device company that is developing breakthrough solutions for mitral valve repair based on its proprietary helix technology. The company is based in Espoo, Finland. The company's lead products, CathHELIX® and MAR®, are transcatheter and surgical mitral valve repair devices that are designed to be faster, easier to use, and less invasive without compromising clinical efficacy. The company was founded by Olli Urho Tapani Keränen, and Tom Fleming has been the CEO of the company since 2022.

BrandBastion Oy provides solutions to protect brands, ads, and communities from social media related risks. It offers protection of ad performance and brand reputation on social media serving governments and global market leaders in several different industries. The company was founded by Jenny-Lin Fanny-Maria Vanessa Wolfram on October 1, 2013 and is headquartered in Helsinki, Finland.

National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD.

PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands.

Nokia International Oy provides telecommunications and network equipment products and services. It also offers applications, games, music, media, digital map information and navigation services. The company is headquartered in Uusimaa, Finland.

Veraventure Oy is a venture capital investment firm based in Kuopio, Finland. Established in 2003, they are a wholly-owned subsidiary of Finnvera Oy. Veraventure is responsible for the management and development of the parent firm's investments linked to regional funds. Finnvera is a specialized financing firm, owned and operated by the Finnish Government and supervised by the Ministry of Trade and Industry. Veraventure specializes in complementing regional markets in equity financing. They have a particular focus on early-stage financing as well as providing capital related to generational changes and for small and mid-size firms. They are the investment manager of the Seed Fund Vera. The firm also has offices in Oulu and Helsinki, Finland.

Finnvera Oyj is a financing company that provides financing for the start-up, growth, and internationalization of enterprises and for protection against export risks. Its products include loans, domestic guarantees, export credit guarantees, venture capital investments, export credits, and interest equalization. The company was founded on July 9, 1998 and is headquartered in Kuopio, Finland.

Nanocomp Oy Ltd. designs and manufactures micro- and nanophotonics solutions. It develops thin foil optics. The firm offers service from design to tooling and mass production of micro- and nanoscale surface structures. It products and services is use for displays; three-dimensional sensing/gesture recognition; laser measuring; wearable devices; and healthcare application. The company was founded by Veli-Pekka Leppänen in 1997 and is headquartered in Lehmo, Finland.

Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ.

Alex Therapeutics AB is a digital therapeutics company that partners with pharmaceutical companies to create and license digital therapies. The company is based in Stockholm, Sweden and was founded by Oliver Fleetwood, John Drakenberg Renander. The Swedish company has a proven "Alex DTX Platform" and expertise in patient-centric design and evidence-based psychology. The company has clinically validated products and overwhelmingly positive patient and partner testimonials. Alex combines cognitive behavioral therapy and AI for behavioral change.

MK Ventures ApS provides investment services. The private company is based in Copenhagen, Denmark. The Danish company was founded by Marko Kuisma and he has been the CEO since incorporation.

M-Files, Inc. provides enterprise content management software. Its solutions include admin tools, authorized service providers, business, capture and OCR, UI extensions, analytics and compliance, integrations, import and export tools, search and navigation, and document vault templates. The company is headquartered in Plano, TX.

Icebreaker Fund Management Oy (Icebreaker.vc) is a venture capital firm founded in 2016 by Riku Seppälä, Aleksi Partanen and Lasse Lehtinen. The firm is headquartered in Helsinki, Finland.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Caris Ltd (Caris) is a private equity firm founded in 2004 by David D. Halbert. The firm is headquartered in Irving, Texas.

Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore.

Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom.